도시미학디앤씨

비상장계속사업자

DOSIMIHAKD&C

김한옥

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

도시미학디앤씨

Business Reg. No. 5948100464 · CEO 김한옥

I.Investment Overview

Target도시미학디앤씨 (5948100464)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명도시미학디앤씨
영문명DOSIMIHAKD&C
대표자김한옥
사업자등록번호5948100464
법인등록번호1101116119998
설립일2016.07.15

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW538.42021145.12022192.22023444.320247032025
영업이익100M KRW105.1202120.92022-20.2202317.5202422.42025
순이익100M KRW58.520215.32022-32.120235.72024132025
Item20252024202320222021
자산총계699.4억원624.6억원627.8억원500.8억원914.1억원
부채총계643.8억원582억원590.9억원431.8억원810.6억원
자본총계55.6억원42.6억원36.9억원69억원103.5억원
매출액703억원444.3억원192.2억원145.1억원538.4억원
영업이익22.4억원17.5억원-20.2억원20.9억원105.1억원
순이익13억원5.7억원-32.1억원5.3억원58.5억원

VI.Financial Ratios

FY2025 basis

3.19%

영업이익률

1.84%

순이익률

1.85%

ROA

23.31%

ROE

1,158.02%

부채비율

7.95%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

도시미학디앤씨 투심보고서 | Alpha Lenz